The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of pan-ErbB inhibitor pyrotinib combined with antiangiogenic agent apatinib for HER2-mutant or amplified metastatic NSCLC: A phase II clinical study.
 
Guangjian Yang
No Relationships to Disclose
 
Haiyan Xu
No Relationships to Disclose
 
Lu Yang
No Relationships to Disclose
 
Shuyang Zhang
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Hongshuai Li
No Relationships to Disclose
 
Yaning Yang
No Relationships to Disclose
 
Xin Ai
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose